Results 31 to 40 of about 229,062 (265)

Recent advances in managing differentiated thyroid cancer [PDF]

open access: yes, 2018
The main clinical challenge in the management of thyroid cancer is to avoid over-treatment and over-diagnosis in patients with lower-risk disease while promptly identifying those patients with more advanced or high-risk disease requiring aggressive ...
Durante, Cosimo   +3 more
core   +2 more sources

131I therapy for hyperthyroidism and consequent appearing of anaplastic carcinoma of the thyroid: simple case-report or real pathophysiologic link?

open access: yesItalian Journal of Medicine, 2013
BACKGROUND 131I is usually employed for the therapy of hyperfunctioning thyroid diseases. This β-emitting radioisotope acts releasing its radiations in small tissue volumes, but it is mandatory to consider, also for the small doses, the carcinogenic risk,
G. Scanelli, B. Traverso, F. Frabetti
doaj   +1 more source

Radionuclide therapy in the treatment of thyroid malignancy [PDF]

open access: yesArchive of Oncology, 2003
In this paper we presented the principles of performance of radionuclide therapy, its adverse effect, together with mentioned complications obligation to use it only according to directions and the success of the therapy, which is seen through the length
Malešević Milica Đ.
doaj   +1 more source

Evaluation of Response to Therapy in Thyroid Carcinoma Patients after Radioactive Iodine Therapy

open access: yesBagcilar Medical Bulletin, 2016
Radioactive iodine therapy is an important treatment modality for differentiated thyroid carcinoma patients. Radioactive iodine, similar to elementary iodine, is concentrated in the thyroid follicular cells after oral application, and it can damage the ...
Lebriz Uslu Besli, Ilhami Uslu
doaj   +1 more source

Factors influencing successful radioiodine therapy of thyroid [PDF]

open access: yesArchive of Oncology, 2003
Background: Well-known fact is that the good surgical treatment, leaving only small residuals of thyroid tissue, is the outmost valid predictive factor of successful ablative radioiodine treatment. Assuming that all patients had state of the art surgical
Popadić Silvija M.   +5 more
doaj   +1 more source

Radioactive Iodine for the Treatment of Subclinical Thyrotoxicosis Grade 1 and 2: Outcome of up to 18-Year Follow Up

open access: yesFrontiers in Endocrinology, 2022
BackgroundSubclinical thyrotoxicosis (SCT) is associated with significant morbidity and mortality, specifically increased risk of atrial fibrillation and cardiovascular death.
Jason Phowira   +14 more
doaj   +1 more source

Cores of production : reactors and radioisotopes in France [PDF]

open access: yes, 2009
This paper concerns the technologies used in radioisotope production in the French Atomic Energy Commission (the Commissariat à l'Energie Atomique) between 1946 and 1958.
Adamson, Matthew
core   +3 more sources

Thyroid cell irradiation by radioiodines: a new Monte Carlo electron track-structure code

open access: yesBrazilian Archives of Biology and Technology, 2007
The most significant impact of the Chernobyl accident is the increased incidence of thyroid cancer among children who were exposed to short-lived radioiodines and 131-iodine.
Christophe Champion   +3 more
doaj   +1 more source

A differentiated approach to complex treatment of radioiodine-induced salivary gland lesions

open access: yesСучасні медичні технології, 2023
The number of patients treated with radioactive iodine for highly differentiated thyroid carcinomas who develop chronic radiation-induced salivary gland lesions is constantly rising, that necessitates the search for new pathogenetically focused ...
A. V. Kopchak, V. А. Makarenko
doaj   +1 more source

Home - About - Disclaimer - Privacy